Publications
Genentech scientists are encouraged to be creative and active members of the scientific community. We are proud of our publication record in Science, Nature, Cell, and other prestigious peer-reviewed journals, where our annual output consistently rivals or surpasses that of the top academic institutions.
|
Analytical and Bioanalytical Chemistry, ISSN: 16182650 16182642
|
|
AAPS Journal, ISSN: 15507416
|
|
Nature Materials, ISSN: 14764660 14761122
|
|
Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS)
The Lancet Haematology,
|
|
Journal of Immunological Methods, ISSN: 18727905 00221759
|
|
British Journal of Dermatology, ISSN: 13652133 00070963
|
|
Journal of Immunological Methods, ISSN: 18727905 00221759
|
|
Journal of Neurology, ISSN: 14321459 03405354
|
|
Convergent Synthesis of PI3K Inhibitor GDC-0908 Featuring Palladium-Catalyzed Direct C-H Arylation toward Dihydrobenzothienooxepines
Journal of Organic Chemistry, ISSN: 00223263
|
|
BMC Cancer, ISSN: 14712407
|
|
Central nervous system metastasis in patients with HER2-positive metastatic breast cancer: Patient characteristics, treatment, and survival from systhers
Clinical Cancer Research, ISSN: 10780432
|
|
Cell Reports, ISSN: 22111247
|
|
Cell Reports, ISSN: 22111247
|
|
Neurobiology of Disease, ISSN: 1095953X 09699961
|
|
Drug Metabolism and Disposition, ISSN: 1521009X 00909556
|
|
Nature Immunology, ISSN: 15292916 15292908
|
|
Cancer Research, ISSN: 15387445 00085472
|
|
Arthritis Care and Research, ISSN: 21514658
|
|
Clinical Cancer Research, ISSN: 15573265 10780432
|
|
Journal of Rheumatology, ISSN: 0315162X
|
|
PLoS ONE, ISSN: 19326203
|
|
Value in Health, ISSN: 15244733 10983015
|
|
Biomedical chromatography : BMC, ISSN: 10990801 02693879
|
|
CPT: Pharmacometrics and Systems Pharmacology, ISSN: 21638306
|
|
Journal of Pathology, ISSN: 10969896 00223417
|
|
Neuro-Oncology Practice, ISSN: 20542585 20542577
|
|
Science, ISSN: 10959203 00368075
|
|
Cancer Cell, ISSN: 18783686 15356108
|
|
Journal of Computer-Aided Molecular Design, ISSN: 15734951 0920654X
|
|
Expert Opinion on Drug Discovery, ISSN: 1746045X 17460441
|
|
Engineered sigma factors increase full-length antibody expression in Escherichia coli
Metabolic Engineering, ISSN: 10967176
|
|
Regulatory Toxicology and Pharmacology, ISSN: 10960295 02732300
|
|
Investigative Ophthalmology and Visual Science, ISSN: 15525783 01460404
|
|
Nature Immunology, ISSN: 15292916 15292908
|
|
Blood advances, ISSN: 24739537
|
|
Cell Chemical Biology, ISSN: 24519448 24519456
|
|
The Autoimmune Susceptibility Gene C5orf30 Regulates Macrophage-Mediated Resolution of Inflammation
Journal of Immunology,
|
|
Clinical Cancer Research, ISSN: 15573265 10780432
|
|
Clinical Cancer Research, ISSN: 15573265 10780432
|
|
New England Journal of Medicine, ISSN: 15334406 00284793
|
|
Structural Basis of Nav1.7 Inhibition by a Gating-Modifier Spider Toxin
Cell, ISSN: 00928674
|
|
Gene, ISSN: 18790038 03781119
|
|
Journal of Pharmaceutical and Biomedical Analysis, ISSN: 1873264X 07317085
|
|
Journal of Pharmaceutical and Biomedical Analysis, ISSN: 1873264X 07317085
|
|
European Journal of Cancer, ISSN: 18790852 09598049
|
|
Fixed Duration of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease and Prolongs Survival: Post-Treatment Follow-Up of the MURANO Phase III Study
Journal of Clinical Oncology,
|
|
Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma
Blood Cancer Journal,
|
